Advanced Oncotherapy (AVO)

 

AVO Share PerformanceMore

52 week high209.88 27/05/16
52 week low47.00 16/12/16
52 week change -79.13 (-51.67%)
4 week volume4,722,784 26/12/16

Media for (AVO)

Presenter: Donatella Ungaro
15/12/2016
Presenter: Nicolas Serandour
12/10/2016

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director Deals - Advanced Oncotherapy PLC (AVO)

Dr Enrico Vanni, Non Executive Director, bought 25,000 shares in the company on the 3rd January 2017 at a price of 87.00...

Director Dealing

RNS Number: 2009T Advanced Oncotherapy PLC 03 January 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Director Dealing Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Dr Enrico Vanni, a Non-Executive Director of the Company, ha...

Director Dealing

RNS Number: 9851S Advanced Oncotherapy PLC 29 December 2016 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Director Dealing Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Dr Enrico Vanni, a Non-Executive Director of the Company, h...

Significant Shareholding Dealing

RNS Number: 9782S Advanced Oncotherapy PLC 29 December 2016 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Significant Shareholding Dealing Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that AB Segulah, a significant shareholder of the C...

Director Deals - Advanced Oncotherapy PLC (AVO)

Dr Enrico Vanni, Non Executive Director, bought 25,000 shares in the company on the 22nd December 2016 at a price of ...

Director Dealing

RNS Number: 6372S Advanced Oncotherapy PLC 22 December 2016 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Director Dealing Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Dr Enrico Vanni, a Non-Executive Director of the Company, ...

Advanced Oncotherapy progress on LIGHT system

Advanced Oncotherapy reports further progress in the technical development of the LIGHT system. Advanced Oncotherap...

Further progress in LIGHT technical development

RNS Number: 5444S Advanced Oncotherapy PLC 22 December 2016 22 December 2016 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Further progress in the technical development of the LIGHT system Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announc...

Fundamental DataMore

EPS-0.51
Dividend yield0 %

Equity Research (AVO)

hardman & co
Advanced Oncotherapy Plc
02/11/2016
AVO is focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN. Planning Permission for its...
Advanced Oncotherapy Plc
01/11/2016
Eco Animal Health (EAH.L) 495p £317.9m The specialist in the development, registration and marketing of pharmaceutical products for animals has received a marketing authorisation from the Thailand...
hardman & co
Advanced Oncotherapy Plc
28/10/2016
AVO is focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN. Planning Permission for its...

Latest discussion posts More

  • Re: Recovery and Director Buys

    Amen! but they've hardly inested a kings' ransom have they? what do you calculate their aggregate outlay cf their remuneration?
    3-Jan-2017
    buy1get1free
  • Recovery and Director Buys

    So the SP is now recovering and we've had some Director buys. things are looking good for 2017, we just need the thing to work now!
    3-Jan-2017
    fish lips
  • Beaufort Securities' view

    Update from Beaufort Securities https://www.research-tree.com/research/breakfast-today/7841a173-b3ee-4a79-8c7d-e2d8973ecec4
    2-Dec-2016
    Sambram

Users' HoldingsMore

Users who hold Advanced Oncotherapy also hold..
LLOYDS GRP.21%
SIRIUS MINERALS15%
TAYLOR WIMPEY12%
BP11%
VODAFONE GRP.11%

Codes & Symbols

ISINGB00BD6SX109
SymbolsAVO, LSE:AVO, AVO.L, AVO:LN, LON:AVO, XLON:AVO